ClinicalTrials.Veeva

Menu

Effectiveness Study of CBT for Anxiety in Children (ATACA)

H

Haukeland University Hospital

Status and phase

Completed
Phase 2

Conditions

Generalized Anxiety Disorder
Social Anxiety Disorder
Separation Anxiety Disorder

Treatments

Behavioral: Cognitive behavioural therapy

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The study aims to evaluate the effectiveness of a cognitive behaviour therapy program (FRIENDS) for anxiety disorders in children aged 8-15 years who have been referred to child and adolescent mental health clinics in Western Norway.

Full description

Cognitive behaviour therapy (CBT) has been shown to be an efficacious treatment for anxiety disorders in youths when delivered in university settings. However, there is a lack of studies evaluating the effectiveness of CBT in regular clinical settings.

The current study will compare a CBT program developed for anxiety in youths (the FRIENDS program by Paula Barrett, Australia), with a wait-list control condition. Group and individual treatment will also be compared in the study. Groups will be divided by age, with younger including 8-12-year-olds, and older 12-15-year-olds. Parents are also involved at the end of all therapy sessions, as well as in separate parent sessions. Assessment and treatment is delivered by clinicians working in seven outpatient clinics in Western Norway.

There will be 10 therapy sessions, with booster sessions 4 and 12 weeks later. Effectiveness will be evaluated post-treatment, and at 1 and 5 years follow-up. The study will have a randomized design. Children randomized to the wait-list condition will be offered treatment if they still meet inclusion criteria after the waiting period.

Enrollment

222 patients

Sex

All

Ages

8 to 15 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Meeting DSM-IV criteria for separation anxiety, social anxiety or generalized anxiety disorder based on the ADIS interview schedule

Exclusion criteria

  • Pervasive developmental disorders, Selective mutism, Mental retardation
  • Having severe obsessional/compulsive, conduct or language problems.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

222 participants in 3 patient groups

Group CBT
Experimental group
Description:
The behavioral intervention FRIENDS (cognitive behavior therapy program developed by P. Barratt) delivered in groups of 4 to 8. 10 weekly sessions plus 2 booster sessions.
Treatment:
Behavioral: Cognitive behavioural therapy
Individual CBT
Experimental group
Description:
The behavioral intervention FRIENDS (cognitive behavior therapy program developed by P. Barratt) delivered individually. 10 weekly sessions plus 2 booster sessions.
Treatment:
Behavioral: Cognitive behavioural therapy
Wait-list control
No Intervention group
Description:
Wait-list control condition for 5 weeks after last child has been included.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems